Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home

Pediatric Population Clinical Trial

— PEDIAOBST  

Official title:

Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04009785
• Other study ID #: Mobilité/2017/GLB
• Status: Completed
• Start date: March 6, 2018
• Est. completion date: June 10, 2018

Study information

• Verified date: June 2019
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Nowadays, resistance to anti-infectives has become a global public health problem and its increased prevalence threatens human health.

To date, few studies have focused on drug compliance in the paediatric population and it varies according to the pathology This drug adherence in the paediatric population is directly linked to outpatient care by the parents or the child's immediate family. In addition, there are no studies on adherence to antibiotics prescribed at the end of hospitalization in the paediatric population.

In this context, it seems urgent to seek an intervention capable of leading to responsible and appropriate use of antibiotics in order to improve efficiency in the drug management of acute paediatric infections.

This pilot study would characterize pediatric patients and determine the compliance rate in this population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: June 10, 2018
• Est. primary completion date: May 4, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 16 Years

Eligibility

Inclusion Criteria:

• The patient is under 16 years of age (< 16 years of age).

• The patient is admitted to a full hospitalization in one of the 2 paediatric units of the University Hospital of Nîmes.

• The patient is discharged with a prescription for anti-infectives to be taken at home, for a maximum of 30 days.

• The patient and the holder of parental authority are available for a follow-up of 1 month after discharge from hospital.

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Anti Infective
• Pediatric Population

Locations

Country	Name	City	State
France	Chu Nimes	Nîmes

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Rate of observing patients who have recovered their anti-infective treatment		2018
Other	Rate of observing patients who have taken anti-infective treatment as prescribed		2018
Other	Sociodemographic and clinical characteristics		2018
Other	Overall success rate in the quiz on understanding anti-infectives		2018
Primary	Rate of patients observing anti-infectives		2018
Secondary	Rehospitalization rates / emergency visits related to worsening infection		2018